These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 32832011)

  • 1. Understanding Diabetic Neuropathy: Focus on Oxidative Stress.
    Pang L; Lian X; Liu H; Zhang Y; Li Q; Cai Y; Ma H; Yu X
    Oxid Med Cell Longev; 2020; 2020():9524635. PubMed ID: 32832011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.
    Figueroa-Romero C; Sadidi M; Feldman EL
    Rev Endocr Metab Disord; 2008 Dec; 9(4):301-14. PubMed ID: 18709457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle.
    Negi G; Kumar A; Joshi RP; Sharma SS
    Biochem Biophys Res Commun; 2011 Apr; 408(1):1-5. PubMed ID: 21439933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of oxidative stress in the development of diabetic neuropathy].
    Sztanek F; Molnárné Molnár Á; Balogh Z
    Orv Hetil; 2016 Dec; 157(49):1939-1946. PubMed ID: 27917671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy.
    Low PA; Nickander KK; Tritschler HJ
    Diabetes; 1997 Sep; 46 Suppl 2():S38-42. PubMed ID: 9285497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant strategies in the management of diabetic neuropathy.
    Oyenihi AB; Ayeleso AO; Mukwevho E; Masola B
    Biomed Res Int; 2015; 2015():515042. PubMed ID: 25821809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Concepts in the Molecular Mechanisms and Management of Diabetic Neuropathy by Pharmacotherapeutics and Natural Compounds.
    Shivam ; Gupta AK; Kumar S
    Cent Nerv Syst Agents Med Chem; 2024; 24(3):264-280. PubMed ID: 38551039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic peripheral neuropathy: current perspective and future directions.
    Singh R; Kishore L; Kaur N
    Pharmacol Res; 2014 Feb; 80():21-35. PubMed ID: 24373831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways.
    Hussain N; Adrian TE
    Curr Diabetes Rev; 2017; 13(5):488-497. PubMed ID: 27341846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy.
    Bönhof GJ; Herder C; Strom A; Papanas N; Roden M; Ziegler D
    Endocr Rev; 2019 Feb; 40(1):153-192. PubMed ID: 30256929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the Role of MicroRNAs in the Onset and Development of Diabetic Neuropathy.
    Simeoli R; Fierabracci A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Insights of Plant Phytochemicals Against Diabetic Neuropathy.
    Balkrishna A; Pathak R; Bhatt S; Arya V
    Curr Diabetes Rev; 2023; 19(9):e250822207994. PubMed ID: 36028963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oxidative stress in diabetic vascular and neural disease.
    Yorek MA
    Free Radic Res; 2003 May; 37(5):471-80. PubMed ID: 12797466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic neuropathy.
    Hayden MR; Tyagi SC
    Med Sci Monit; 2004 Dec; 10(12):RA291-307. PubMed ID: 15567993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical manifestations and current treatment options for diabetic neuropathies.
    Casellini CM; Vinik AI
    Endocr Pract; 2007 Sep; 13(5):550-66. PubMed ID: 17872358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Kaempferol isolated from seeds of Eruca sativa on changes of pain sensitivity in Streptozotocin-induced diabetic neuropathy.
    Kishore L; Kaur N; Singh R
    Inflammopharmacology; 2018 Aug; 26(4):993-1003. PubMed ID: 29159712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic neuropathy and oxidative stress.
    Pop-Busui R; Sima A; Stevens M
    Diabetes Metab Res Rev; 2006; 22(4):257-73. PubMed ID: 16506271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in the pathogenesis of diabetic neuropathy.
    Vincent AM; Russell JW; Low P; Feldman EL
    Endocr Rev; 2004 Aug; 25(4):612-28. PubMed ID: 15294884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.